Skip to main content
. 2019 Jul 31;14(7):e0220451. doi: 10.1371/journal.pone.0220451

Table 3. Association between PAH-DNA adducts and immune cell phenotypes (n = 179).

Cell phenotype aΔR2 (%) bp-value cFDR dB1 (se) dB2 (se) dB3 (se)
T-cell 9.88 <0.0001 0.0004 -2.19 (1.12) -5.37 (1.22) ---
Th-cell 14.45 <0.0001 <0.0001 -4.49 (1.75) -4.19 (0.96) 2.79 (1.36)
log(CTL) 0.10 0.68 0.68 0.02 (0.04) --- ---
log(B cell) 1.29 0.09 0.17 0.07 (0.04) --- ---
Monocyte CD14+ 9.28 0.0001 0.0004 0.53 (0.52) 2.48 (0.57) ---
T memory cell 6.10 0.003 0.009 -2.17 (0.92) -3.13 (1.01) ---
log(Activated B) 0.87 0.17 0.27 0.06 (0.05) --- ---
log(Monocyte CD14+CD16+) 0.17 0.58 0.63 0.047 (0.08) --- ---
log(NK) 2.87 0.08 0.16 0.11 (0.07) 0.16 (0.08) ---
log(NKT) 0.27 0.48 0.59 -0.07 (0.10) --- ---
IL7α Receptor (n = 178) 0.36 0.43 0.29 0.69 (0.87) --- ---

Note: All estimates are from linear models with polynomials of exposure variable X, adjusted for age, BMI, ever smoked and effect of UAs/Cr

aΔR2: The change in R2 for percent of variation in outcome explained by the effect of PAH-DNA adducts adjusting for other variables.

bp-value was from likelihood ratio test for the effect of PAH-DNA adducts, possibly non-monotonic.

cFDR: False discovery rate

dB1: Estimated coefficient of X; B2: estimated coefficient of X2, B3: estimated coefficient of X3; for X = log(PAH-DNA adducts /1.8357).

se: Standard error